ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.60
+0.25 (3.94%)
Mar 6, 2026, 4:00 PM EST - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $59.70 million as of March 6, 2026. Its market cap has increased by 33.72% in one year.
Market Cap
59.70M
Enterprise Value
69.42M
1-Year Change
33.72%
Ranking
Category
Stock Price
$6.60
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $59.70M, an increase of 2,897.12%. That is a compound annual growth rate of 10.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 63.73M |
| Mereo BioPharma Group | 62.71M |
| ImageneBio | 62.20M |
| eXoZymes | 61.43M |
| NeurAxis | 60.83M |
| Instil Bio | 60.16M |
| Spruce Biosciences | 59.80M |
| Grace Therapeutics | 59.73M |